Relation of Mycobacterium tuberculosis mutations at katG315 and inhA-15 with drug resistance profile, genetic background, and clustering in Argentina

dc.creatorMonteserin, Johana
dc.creatorPaul, Roxana
dc.creatorLatini, Cecilia
dc.creatorSimboli, Norberto
dc.creatorYokobori, Noemi
dc.creatorDelfederico, Lucrecia
dc.creatorLópez, Beatriz
dc.creatorRitacco, Viviana
dc.date2020-12-21T20:57:10Z
dc.date2020-12-21T20:57:10Z
dc.date2017-11
dc.date.accessioned2023-08-29T20:08:06Z
dc.date.available2023-08-29T20:08:06Z
dc.identifier0732-8893
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/1971
dc.identifier10.1016/j.diagmicrobio.2017.07.010
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8519999
dc.descriptionFil: Monteserin, Johana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Paul, Roxana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Latini, Cecilia. Hospital "Dr. F. J. Muñiz", Buenos Aires; Argentina.
dc.descriptionFil: Simboli, Norberto. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Yokobori, Noemi. Instituto de Medicina Experimental (IMEX) - CONICET, Academia Nacional de Medicina, Ciudad Autónoma de Buenos Aires; Argentina.
dc.descriptionFil: Delfederico, Lucrecia. Laboratorio de Microbiología Molecular, Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Bernal; Argentina.
dc.descriptionFil: López, Beatriz. . ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionWe analyzed 362 isoniazid-resistant clinical isolates of Mycobacterium tuberculosis obtained countrywide for the presence of mutation at katG315 and inhA-15 in relation to genotype, pattern of phenotypic resistance to other drugs, and ability to spread. We found the following mutation frequencies: katG315MUT/inhA-15wt 53.0%, katG315wt/inhA-15MUT 27.4%, katG315wt/inhA-15wt 19.3%, and katG315MUT/inhA-15MUT only 0.3%. Mutation at katG315 associated with the LAM superfamily; mutation at inhA-15 associated with the S family and the T1 Tuscany genotype; the combination katG315wt/inhA-15wt associated with the T1 Ghana genotype. Isolates harboring katG315MUT/inhA-15wt tended to accumulate resistance to other drugs and were more frequently found in cluster; isolates harboring katG315wt/inhA-15wt were more frequently found as orphan isolates. Although epidemiological and host factors could also be modulating the events observed, in Argentina, the systematic genotyping of drug resistant clinical isolates could help to predict an enhanced risk of transmission and a propensity to develop resistance to increasing numbers of drugs.
dc.languageen
dc.publisherElsevier
dc.relationDiagnostic microbiology and infectious disease
dc.rightsnone
dc.sourceDiagnostic Microbiology and Infectious Disease 2017; 89(3):197-201.
dc.subjectResistencia a Múltiples Medicamentos
dc.subjectAnálisis por Conglomerados
dc.subjectGenotipo
dc.subjectIsoniazida
dc.titleRelation of Mycobacterium tuberculosis mutations at katG315 and inhA-15 with drug resistance profile, genetic background, and clustering in Argentina
dc.typeArtículo


Este ítem pertenece a la siguiente institución